CONTINUOUS CISPLATIN INFUSION IN COMBINATION WITH VINCRISTINE AND HIGH-DOSE METHOTREXATE FOR ADVANCED OSTEOGENIC-SARCOMA

被引：10

作者：

GASPARINI, M ^{[1
]}

TONDINI, C ^{[1
]}

ROTTOLI, L ^{[1
]}

RONCORONI, I ^{[1
]}

机构：

[1] IST NAZL STUDIO & CURA TUMORI,I-20133 MILAN,ITALY

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1987年 / 10卷 / 02期

关键词：

D O I：

10.1097/00000421-198704000-00051

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：152 / 155

页数：4

共 16 条

[1]

BAUM ES, 1979, CANCER TREAT REP, V63, P1621

[2]

BULL FE, 1976, P AM ASSOC CANC RES, V17, P249

[3] THE EFFECT OF PRIOR CISPLATIN THERAPY ON THE PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE [J].

CROM, WR ;

PRATT, CB ;

GREEN, AA ;

CHAMPION, JE ;

CROM, DB ;

STEWART, CF ;

EVANS, WE .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :655-661

[4]

DREWINKO B, 1973, CANCER RES, V33, P3091

[5]

DREWINKO B, 1980, CISPLATIN CURRENT ST, P37

[6]

EDMONSON JH, 1981, CANCER TREAT REP, V65, P538

[7]

GASPARINI M, 1985, CANCER TREAT REP, V69, P211

[8]

GASPARINI M, 1983, P ASCO, V2, P239

[9]

ISACOFF WH, 1978, CANCER TREAT REP, V62, P1295

[10]

MORGAN E, 1984, CANCER TREAT REP, V68, P661

← 1 2 →